In 2021, the EU dental bone graft substitutes market size is projected to reach $272 million, which is a recovery of over 30% when compared to 2020. In spite of COVID19, the EU market size is expected to increase over the forecast period to exceed $372 million in 2027. Currently, over 40% of the dental bone graft substitutes market share in Europe is dominated by two main competitors – Geistlich and Botiss Biomaterials.

The growing number of GPs placing implants is driving the European market for dental bone graft substitutes forward by increasing the volume of dental implant procedures. The growing number of GPs placing implants increases the probability that a patient is informed on the importance of having a sufficient level of bone in their jaw prior to the procedure. Ultimately, this will result in a greater number of patient referrals to specialists for dental regenerative procedures that incorporate dental biomaterials.

The European dental bone graft substitutes market is expected to grow based on aging population, brand name recognition, bundling of implants, and bone graft substitutes and membranes. As the population ages, they will have better dentition than previous generations, shrinking the pool of potential patients for bone grafting procedures.

MAJOR SEGMENTS COVERED IN THE DENTAL BONE GRAFT SUBSTITUTES MARKET REPORT SUITE

While this report suite contains all applicable market data, each of the market segments are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:

• Market Overview for Dental Bone Graft Substitutes – MedView – Gives an easily accessible view of all dental bone graft substitutes markets and trends and aggregates the data together for a picture of the total European market.
• Procedure Numbers for Dental Bone Graft Substitutes – MedPro – Using a number of databases, internal and external, we’re able to provide you with the total volume of dental bone graft substitute procedures being performed for each of the markets mentioned in this suite of reports.
• Market Report for Dental Bone Graft Substitutes – MedCore – The market for dental bone graft substitutes is segmented into allograft, xenograft, and synthetic markets.
• Market Report for Dental Growth Factor – MedCore – The market for dental growth factor is comprised of the Emdogain market, the GEM 21S market, the INFUSE market, and the Osteocel market.
• Market Report for Dental Barrier Membranes – MedCore – The market for dental barrier membranes is separated into resorbable and non-resorbable membrane markets.

Buying all of these reports together in this suite package will provide you with substantial discounts from the separate prices. Request Pricing to Learn More

MARKET REPORT DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Value & Growth Trends
• 10 Year Scope
• Market Drivers & Limiters for Each Segment
• Competitive Analysis with Market Shares for Each Segment
• Recent Mergers & Acquisitions
• Disease Overviews and Demographic Information
• Company Profiles, Product Portfolios and SWOT for Top Competitors
• Related Press Releases from Top Competitors

COMPANIES ANALYZED

Of the many companies in the EU dental bone graft substitutes market, Geistlich maintained its leading position in the European dental biomaterial market, owing to its dominant presence in the dental bone graft substitute and dental barrier membrane markets. Botiss Biomaterials was the second leading dental biomaterial company in Europe. The company continues to benefit from its distribution partnership with Straumann. Other notable competitors include Zimmer Biomet, Non-Profit Tissue Banks, BioHorizons and numerous dental implant companies which have entered the dental biomaterial market.